Rhee et al. from Alfred Ayala’s laboratory first reported that treating 129S1/SvImJ mice with an anti-CD1d mAb (clone 1B1) before the CLP surgery could reduce plasma and splenic IL-6 and IL-10 levels and prevented sepsis-induced mortality in some of the treated mice (207). The gene discussed is CD1D; the disease is Sepsis.